Table 1.
Patient and Pathologic Characteristics.
| Patient and Pathologic Characteristics, No. (%) | All Patients 102 (100.0%) | Brain Metastasis 17 (16.7%) |
|---|---|---|
| Age (Mean) | 65.7 | 62.2 |
| Gender | ||
| Male | 60 (58.8%) | 11 (64.7%) |
| Female | 42 (41.2%) | 6 (35.3%) |
| Race | ||
| Non-Hispanic White | 89 (87.3%) | 3 (17.6%) |
| African American | 12 (11.8%) | 14 (82.4%) |
| Other | 1 (1.0%) | 0 (0.0%) |
| Pathology | ||
| Adenocarcinoma | 55 (53.9%) | 10 (58.4%) |
| Squamous cell Carcinoma | 29 (28.4%) | 5 (29.4%) |
| Non-small cell (not further specified) | 17 (16.7%) | 2 (11.8%) |
| Other | 1 (1.0%) | 0 (0.0%) |
| T-Stage (TNM at diagnosis) | ||
| Tis | 1 (1.0%) | 0 (0.0%) |
| I | 9 (8.9%) | 0 (0.0%) |
| Ia | 10 (9.9%) | 0 (0.0%) |
| Ib | 13 (12.9%) | 0 (0.0%) |
| II | 15 (14.9%) | 2 (11.8%) |
| IIa | 10 (9.9%) | 1 (5.9%) |
| IIb | 3 (3.0%) | 0 (0.0%) |
| III | 18 (17.8%) | 3 (17.6%) |
| IV | 22 (21.8%) | 11 (64.7%) |
| N-Stage | ||
| Nx | 1 (1.0%) | 0 (0.0%) |
| N0 | 42 (41.6%) | 1 (5.9%) |
| N1 | 8 (7.9%) | 1 (5.9%) |
| N2 | 28 (27.7%) | 5 (29.4%) |
| N3 | 22 (21.8%) | 10 (58.8%) |
| M-Stage | ||
| M0 | 60 (59.4%) | 4 (23.5%) |
| M1 | 4 (4.0%) | 1 (5.9%) |
| M1a | 3 (3.0%) | 1 (5.9%) |
| M1b | 29 (28.7%) | 11 (64.7%) |
| Mx | 5 (5.0%) | 0 (0.0%) |
TNM: tumor node metastasis.
*
TNM staging at time of diagnosis.